Category European Union

COMBINE programme launches a pilot coordinated assessment for clinical trials and performance studies

Last updated: 27 June 2025 To view updates, click on the ‘+’ sign below. What is COMBINE? COMBINE is one of the initiatives highlighted in the Draghi report to support EU competitiveness in clinical research. When did the COMBINE Project 1 –…

Read MoreCOMBINE programme launches a pilot coordinated assessment for clinical trials and performance studies

EU launches Phase 2 of the Simultaneous National Scientific Advice (SNSA) pilot

Last updated: 27 May 2025 To see updates, click on the ‘+’ sign below The EU Innovation Network (EU IN) has launched Phase 2 of the simultaneous national scientific advice (SNSA) pilot. The EU IN started Phase 1 of the pilot for Simultaneous National Scientific…

Read MoreEU launches Phase 2 of the Simultaneous National Scientific Advice (SNSA) pilot

European Commission initiative on compulsory licensing of patented inventions and Supplementary Protection Certificates

Last updated: 18 March 2024 See updates at the end of the post. On 27 April 2023, the Commission proposed new rules to help companies, especially small and medium-sized companies (SMEs), make the most of their inventions, leverage new technologies…

Read MoreEuropean Commission initiative on compulsory licensing of patented inventions and Supplementary Protection Certificates

Medical Device Coordination Group updates: October – December 2023

Guidance No. About the guidance MDCG 2023-7 Guidance on exemptions from the requirements to perform clinical investigations pursuant to Article 61(4)-(6) MDR – December 2023 This guidance is intended to clarify the exemptions from the requirement to perform clinical investigations…

Read MoreMedical Device Coordination Group updates: October – December 2023

Using the outcome of Case T-611/18 (Pharmaceutical Works Polpharma S.A vs the EMA) to better understand aspects of EU medicines legislation

Last updated: 21 December 2023 See updates at the end of the post. The parties involved in the case The parties involved in this case were Pharmaceutical Works Polpharma S.A versus the European Medicines Agency (Case T-611/18) supported by the…

Read MoreUsing the outcome of Case T-611/18 (Pharmaceutical Works Polpharma S.A vs the EMA) to better understand aspects of EU medicines legislation